Restoration of Vision and Retinal Responses After Adeno-Associated Virus–Mediated Optogenetic Therapy in Blind Dogs
Sergei Nikonov(Penn Presbyterian Medical Center), Jean Bennett(Penn Presbyterian Medical Center), Puya Aravand(Penn Presbyterian Medical Center), Tomás S. Alemán(Children's Hospital of Philadelphia), Ivan Shpylchak(Penn Presbyterian Medical Center), Arkady Lyubarsky(Penn Presbyterian Medical Center), Rachel M. Huckfeldt(Penn Presbyterian Medical Center), Keirnan Willett(Penn Presbyterian Medical Center), Roman Nikonov(Penn Presbyterian Medical Center), Pavitra S. Ramachandran(Penn Presbyterian Medical Center), Albert M. Maguire(Children's Hospital of Philadelphia), Angela J. Luo(Penn Presbyterian Medical Center), Zhangyong Wei(Penn Presbyterian Medical Center), Nicholas T. Phelps(Penn Presbyterian Medical Center)
Cited by 19
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Treatment of Leber Congenital Amaurosis Due to <i>RPE65</i> Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
|Human Gene Therapy|2008|950
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|864